Chinese investor behind Y Cannabis poised to take full control of Tasmanian Botanics in A$31m deal by Adam Sheldon December 2, 2025December 4, 2025 The Chinese part-owner of Tasmanian Botanics is set to take almost full control of the Australian […]
News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing by Adam Sheldon December 2, 2025February 21, 2026
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
InhaleRx locks in A$1m cap raise and reveals plans to rebrand by Adam Sheldon December 1, 2025February 21, 2026
Biortica formally ends RTO bid and targets ASX listing in early 2026 by Steve Jones November 27, 2025December 4, 2025
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
Medicinal cannabis works. What’s broken is the culture around it by Dr Afraz Adams November 27, 2025November 27, 2025
Debt-laden Cannim poised for liquidation as potential buyers walk away by Steve Jones November 27, 2025December 2, 2025
Women are cannabis reform’s ‘greatest untapped potential’ by Adam Sheldon November 26, 2025November 27, 2025
Compliance gaps, slow licensing and strict rules put Australia at risk on global stage, expert warns by Adam Sheldon November 26, 2025November 26, 2025
